ConductScience.org, home

Paper167941

Carcinogenicity of nitrosation products of ephedrine, sarcosine, folic acid, and creatinine.

Wogan GN and 3 others. Cancer Res, 1975. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. Carcinogenicity of nitrosation products of ephedrine, sarcosine, folic acid, and creatinine. Papers, record 167941. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/167941

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Carcinogenicity of nitrosation products of ephedrine, sarcosine, folic acid, and creatinine.
PubMed
Journal
Cancer Res
PubMed
Year
1975
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
2.07
iCite
Revised in PubMed
2013-11-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wogan GNG N
2Paglialunga SS
3Archer MCM C
4Tannenbaum SRS R

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CarcinogensMajor topic
CarcinomaMajor topic
Liver NeoplasmsMajor topic
Lung NeoplasmsMajor topic
Nitroso CompoundsMajor topic
Adenoma, Bile Duct
Animals
Creatinine
Ephedrine
Folic Acid
Hyperplasia
Lethal Dose 50
Mice
Mice, Inbred C3H
Mice, Inbred C57BL
Neoplasms, Experimental
Neurofibroma
Nitro Compounds
Precancerous Conditions
Sarcosine

Source PubMed

Download CSV of topics

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
40639678Genotoxicity evaluation of ten nitrosamine drug substance-related impurities using 2D and 3D HepaRG cell models.Regul Toxicol Pharmacol2025https://conductscience.org/library/papers/40639678PubMed
39433234Mutagenicity and genotoxicity evaluation of 15 nitrosamine drug substance-related impurities in human TK6 cells.Regul Toxicol Pharmacol2024https://conductscience.org/library/papers/39433234PubMed
39343352Optimizing the detection of N-nitrosamine mutagenicity in the Ames test.Regul Toxicol Pharmacol2024https://conductscience.org/library/papers/39343352PubMed
36999063Risk assessment of N-nitrosamines in food.EFSA J2023https://conductscience.org/library/papers/36999063PubMed
21432386Genotoxic effects of N-nitrosoketamine and ketamine as assessed by in vitro micronucleus test in Chinese hamster lung fibroblast cell line.Environ Health Prev Med2006https://conductscience.org/library/papers/21432386PubMed
4068803Vitamin deficiency and cancer.Med Oncol Tumor Pharmacother1985https://conductscience.org/library/papers/4068803PubMed
588420A method for detecting carcinogenic organic chemicals using mammalian cells in culture.Br J Cancer1977https://conductscience.org/library/papers/588420PubMed
354672An evaluation of 6 short-term tests for detecting organic chemical carcinogens.Br J Cancer1978https://conductscience.org/library/papers/354672PubMed
98173Structural analysis as a means of predicting carcinogenic potential.Br J Cancer1978https://conductscience.org/library/papers/98173PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/167941

GET https://conductscience.org/api/papers/v1/167941/authors